CHRS is Coherus Oncology, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $1.42. Market cap: $219M. Capital Quality Rank: 32/100 — Stagnant mediocrity.
Stock snapshot
| Price | $1.42 |
| Market cap | $219M |
| Sector | Healthcare |
| Exchange | NGM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 32 / 100 · Stagnant mediocrity |
| ROIC (TTM) | -1557.8% |
| Revenue CAGR (3y) | -41.5% |
| Shareholder buyback yield | -2.21% |
| Altman Z-score zone | Distress |
About CHRS
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.
Related non-dividend companies
Other non-dividend stocks investors research alongside CHRS. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is CHRS's current stock price?
CHRS (Coherus Oncology, Inc.) is currently trading at $1.42.
Does CHRS pay a dividend?
CHRS (Coherus Oncology, Inc.) does not currently pay a regular dividend.
What is CHRS's Capital Quality Rank?
CHRS has a Capital Quality Rank of 32/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track CHRS in DiviDrip
Add CHRS to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search CHRS and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.